SCHEMBL7129415

SCHEMBL7129415

Fc1cc2nc([AsH2])[nH]c2cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CBFB Q13951 1/20 0.45
▸ CYP11B2 P19099 1/20 0.41
▸ PDE10A Q9Y233 2/20 0.39
▸ EGLN1 Q9GZT9 1/20 0.39
▸ F10 P00742 1/20 0.39
▸ HRH4 Q9H3N8 2/20 0.37
▸ HRH3 Q9Y5N1 2/20 0.37
▸ HDAC11 Q96DB2 1/20 0.35
▸ TXN P10599 1/20 0.35
▸ GPR84 Q9NQS5 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171206 0.77 ALDH1A1 (0.67) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL14278 0.74 FABP6 (0.59) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL7991998 0.74 KDM4E (0.55) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL213270 0.74 KDM4E (0.49) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL1193108 0.74 ALDH1A1 (0.49) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL4107335 0.74 HSD17B10 (0.61) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL7214338 0.70 KDM4E (0.43) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL3828091 0.69 OPRL1 (0.60) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL16810842 0.69 TDP1 (0.54) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL12264335 0.69 GAA (0.62) KDM4EHSD17B10ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144286-A1 Benzimidazole derivatives TULARIK, INC 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144286-A1 Benzimidazole derivatives NFATC1, STAT1, IRF3 KDM4E 924/4885HSD17B10 3670/4885ALDH1A1 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback